UNC Chapel Hill / Lineberger Comprehensive Cancer — Chapel Hill, North Carolina

UNC Chapel Hill / Lineberger Comprehensive Cancer is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UNC Chapel Hill / Lineberger Comprehensive Cancer has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Pancreatic Ductal.

Sponsors: Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UNC Chapel Hill / Lineberger Comprehensive Cancer?

UNC Chapel Hill / Lineberger Comprehensive Cancer has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UNC Chapel Hill / Lineberger Comprehensive Cancer conducted?

UNC Chapel Hill / Lineberger Comprehensive Cancer has 1 clinical trials on record. Their work covers Carcinoma, Pancreatic Ductal.

Is UNC Chapel Hill / Lineberger Comprehensive Cancer accredited by Crixeo Health?

UNC Chapel Hill / Lineberger Comprehensive Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UNC Chapel Hill / Lineberger Comprehensive Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.